首页 | 本学科首页   官方微博 | 高级检索  
     

吉西他滨联合顺铂治疗晚期乳腺癌的临床观察
引用本文:王彩玲,王俊生. 吉西他滨联合顺铂治疗晚期乳腺癌的临床观察[J]. 中国肿瘤临床与康复, 2010, 0(1): 47-48
作者姓名:王彩玲  王俊生
作者单位:安阳市肿瘤医院;
摘    要:
目的观察吉西他滨联合顺铂治疗晚期乳腺癌的疗效及不良反应。方法47例晚期乳腺癌患者采用吉西他滨1000mg/m^2,静脉滴注30min,d1,d8;顺铂25~40mg/m^2,d2~4。21d一周期,治疗2周期后评价疗效及不良反应。结果47例均可评价疗效,共完成周期数为206个。完全缓解(CR)4例,部分缓解(PR)17例,稳定(SD)15例,进展(PD)11例,总有效率(CR+PR)44.7%,疾病控制率(CR+PR+SD)76.6%,中位疾病进展时间8.7个月,中位生存期为12.3个月(2.0~52.5个月)。主要不良反应为骨髓抑制、胃肠道反应。结论吉西他滨联合顺铂治疗晚期乳腺癌疗效较好,毒副反应轻,耐受性好,是晚期乳腺癌的有效治疗方案。

关 键 词:吉西他滨  顺铂  乳腺肿瘤/化学疗法

Clinical observation of 47 patients with advanced breast cancer treated with gemcitabine combined with cisplatin
WANG Cai-ling,WANG Jun-sheng. Clinical observation of 47 patients with advanced breast cancer treated with gemcitabine combined with cisplatin[J]. Chinese Journal of Clinical Oncology and Rehabilitation, 2010, 0(1): 47-48
Authors:WANG Cai-ling  WANG Jun-sheng
Affiliation:WANG Cai-ling,WANG Jun-sheng(Anyang Tumor Hospital,Anyang 455000,China)
Abstract:
Objective To study the efficacy and toxic effects of gemcitabine combined with cisplatin in treating patients with advanced breast cancer.Methods Forty-seven patients with advanced breast cancer were treated with gemcitabine 1000 mg/m2 on day1and day8,cisplatin 25-40 mg/m2on days 2-4.The chemotherapy repeated every 3 weeks.Efficacy and toxic reactions were reviewed after 2 cycles of chemotherapy.Results Forty-seven patients were evaluable for response:CR 4 cases,PR 17cases,SD 15cases,and PD 11cases.The over...
Keywords:Gemcitabine  Cisplatin  Breast neoplasms/chemotherapy  
本文献已被 CNKI 维普 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号